Publications by authors named "Lars Ehlers"

Claim this Profile
H
Healthcare Costs Associated With Anabolic Steroid Use: A Cohort Study.
Henrik Horwitz, Renée Hangaard Olesen, Josefine Windfeld-Mathiasen, Kim Peder Dalhoff, Jon Trærup Andersen, Lars Holger Ehlers

Scand J Med Sci Sports· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing patient access to faecal microbiota transplantation with remote delivery: a cost analysis of outpatient versus home-based treatment.
Renée Hangaard Olesen, Emma Bendix Larsen, Tone Rubak, Simon Mark Dahl Baunwall, Sara Ellegaard Paaske, Lars Holger Ehlers

Health Econ Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Hospital-at-Home and Fecal Microbiota Transplantation in Treating Older Patients With Clostridioides difficile.
Renée Hangaard Olesen, Emma Bendix Larsen, Tone Rubak, Simon Mark Dahl Baunwall, Sara Ellegaard Paaske, Lars Holger Ehlers

Clin Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global barriers to decision makers for prioritizing interventions for obesity.
Lars Holger Ehlers, Nicoline Weinreich Reinstrup, Renée Hangaard Olesen, Jens-Christian Holm, Phil McEwan

Int J Obes (Lond)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study.
Matilde Slot, Thomas Bøjer Rasmussen, Mette Nørgaard, Carsten Schade Larsen, Lars Holger Ehlers

Pharmacoecon Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing teleophthalmology services to improve cost-effectiveness of the national eye care system.
E P Jørgensen, D V Muttuvelu, T Peto, S Natarajan, J Davies, Lars Holger Ehlers

Eye (Lond)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-reduction trials in oncology - aiming for less toxicity and better quality of life at lower costs.
Kim Theilgaard-Mönch, Lars Holger Ehlers

Nat Rev Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus.
Henrik Vitus Bering Laursen, Emmelie Ploug Jørgensen, Peter Vestergaard, Lars Holger Ehlers

Pharmacoeconomics· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does a corticosteroid injection plus exercise or exercise alone add to the effect of patient advice and a heel cup for patients with plantar fasciopathy? A randomised clinical trial.
Henrik Riel, Bill Vicenzino, Jens Lykkegaard Olesen, Martin Bach Jensen, Lars Holger Ehlers

Br J Sports Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Costs at the End of Life for Patients with Non-cancer Diseases and Cancer in Denmark.
Anne Høy Seemann Vestergaard, Lars Holger Ehlers, Mette Asbjoern Neergaard, Christian Fynbo Christiansen, Jan Brink Valentin

Pharmacoecon Open· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy.
Lars Børty, Rasmus F Brøndum, Heidi S Christensen, Charles Vesteghem, Marianne Severinsen, Lars H Ehlers

Eur J Health Econ· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of targeted treatment vs chemoimmunotherapy in treatment-naive unfit CLL without TP53 aberrations.
Matilde Slot, Carsten Utoft Niemann, Lars Holger Ehlers, Emelie Curovic Rotbain

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is known and what is still unknown within chronic musculoskeletal pain? A systematic evidence and gap map.
Kristian D Lyng, Chris Djurtoft, Malene K Bruun, Mads N Christensen, Rikke E Lauritsen, Lars H Ehlers

Pain· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Economic Assessment of Faecal Microbiota Transplantation for Patients with Urinary Tract Infections Caused by Multidrug-Resistant Organisms.
Olivia Dybro Baek, Camilla K Hjermitslev, Line Dyreborg, Simon M D Baunwall, Katrine L Høyer, Lars H Ehlers

Infect Dis Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Participatory research: a Priority Setting Partnership for chronic musculoskeletal pain in Denmark.
Kristian D Lyng, Jesper B Larsen, Kathryn A Birnie, Jennifer Stinson, Morten S Hoegh, Lars H Ehlers

Scand J Pain· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of non-communicable diseases in people living with HIV in the Central Denmark Region.
Lars Holger Ehlers, Flemming Axelsen, Thomas Bøjer Rasmussen, Jens Dollerup, Nils Abild Jespersen

HIV Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalog of EQ-5D-3L Health-Related Quality-of-Life Scores for 199 Chronic Conditions and Health Risks in Denmark.
Michael Falk Hvidberg, Karin Dam Petersen, Michael Davidsen, Flemming Witt Udsen, Anne Frølich, Lars Ehlers

MDM Policy Pract· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Utilization and Costs for Empagliflozin Versus Glucagon-Like Peptide-1 Receptor Agonists in Routine Clinical Care in Denmark.
Reimar W Thomsen, Lotte W B Christensen, Johnny Kahlert, Jakob S Knudsen, Anastasia Ustyugova, Lars H Ehlers

Diabetes Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competitive tenders on analogue hospital pharmaceuticals in Denmark 2017-2020.
Lars Holger Ehlers, Morten B Jensen, Henrik Schack

J Pharm Policy Pract· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The analogue substitution model: Introducing competition in the absence of generic substitution in Danish hospitals.
Elisabeth Christensen, Niels Christian Hirsch, Jonas Valbjørn Andersen, Lars Holger Ehlers

Health Policy· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Effectiveness of Blended Cognitive Behavioral Therapy Compared With Face-to-Face Cognitive Behavioral Therapy for Adult Depression: Randomized Controlled Noninferiority Trial.
Kim Mathiasen, Tonny E Andersen, Mia Beck Lichtenstein, Lars Holger Ehlers, Heleen Riper

J Med Internet Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare Sector Setting.
Sabine Michelsen Raunbak, Anne Sig Sørensen, Louise Hansen, Flemming Skjøth, Torben Bjerregaard Larsen, Lars Holger Ehlers

Pharmacoecon Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation alongside a randomized controlled trial of blended cognitive-behavioral therapy for patients suffering from major depressive disorder.
Astrid Langergaard, Kim Mathiasen, Jesper Søndergaard, Sabrina S Sørensen, Sidsel L Laursen, Lars H Ehlers

Internet Interv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with recurrent infections.
Lianna H Hammeken, Simon M D Baunwall, Jens F Dahlerup, Christian L Hvas, Lars H Ehlers

Therap Adv Gastroenterol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark.
Lars H Ehlers, Mark Lamotte, Mafalda C Ramos, Susanne Sandgaard, Pia Holmgaard

Diabetes Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis